KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.25
+0.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 24.34x
- Price / sales
- 15.26x
- Price / cash flow
- -10.55x
Enterprise value
- Enterprise value
- $684.2M
- EV / sales
- 8.86x
- EV / EBITDA
- -2.34x
- EV / EBIT
- -2.15x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026